Site icon The Commune

Amid Quad summit, India to manufacture J&J’s single-dose COVID-19 vaccine

India J&J vaccine Quad COVID-19 patent waiver

As the Quad nations held their maiden leaders’ summit on 12 March, India is now set to manufacture the single-dose COVID-19 vaccine developed by the United States based pharmaceutical giant Johnson & Johnson (J&J), reports Times of India.

India will manufacture the vaccines as part of the first Quad vaccine initiative. The Quad is a group of USA, India Japan and Australia, and is considered a lynchpin of the Indo-Pacific strategy against China. 

The entire project will be financed by Japan and the US. Australia will provide its logistics capabilities to ship the “Made in India” vaccines to Southeast Asia and Pacific nations.

India’s responsibility will be to reinforce its credentials as a trustworthy and reliable manufacturer and supplier of quality vaccines and maintain its primacy as the “pharmacy of the world”.

The Quad leaders’ maiden summit is an important event where Prime Ministers (PMs) Narendra Modi, Yoshihide Suga, Scott Morrison and President Joe Biden together discuss and advance mutual interests in the Indo-Pacific region.

Click here to subscribe to The Commune on Telegram and get the best stories of the day delivered to you personally.

Exit mobile version